These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2219397)

  • 1. Induction of tolerance after facilitation of engraftment with a monoclonal antibody anti-MHC class II in MHC fully allogeneic transplantation.
    Hamelmann E; Wottge HU; Gassmann W; Uharek L; Müller-Ruchholtz W
    Transplant Proc; 1990 Oct; 22(5):2340-1. PubMed ID: 2219397
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of stable long-term mixed hematopoietic chimerism following nonmyeloablative conditioning with T cell-depleting antibodies, cyclophosphamide, and thymic irradiation leads to donor-specific in vitro and in vivo tolerance.
    Mapara MY; Pelot M; Zhao G; Swenson K; Pearson D; Sykes M
    Biol Blood Marrow Transplant; 2001; 7(12):646-55. PubMed ID: 11787527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetic analysis of fully allogeneic rat bone marrow transplantation.
    Marquarding E; Klempnauer J; Steiniger B; Filler G; Wonigeit K; Pichlmayr R
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2715-7. PubMed ID: 3274582
    [No Abstract]   [Full Text] [Related]  

  • 4. Sirolimus promotes tolerance for donor and recipient antigens after MHC class II disparate bone marrow transplantation in rats.
    Jäger MD; Liu JY; Timrott KF; Popp FC; Stoeltzing O; Lang SA; Piso P; Geissler EK; Schlitt HJ; Dahlke MH
    Exp Hematol; 2007 Jan; 35(1):164-70. PubMed ID: 17198885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance induction to murine class II MHC molecules by anti-CD4 antibody.
    Wheelahan J; McKenzie IF
    Transplant Proc; 1989 Feb; 21(1 Pt 1):246-7. PubMed ID: 2650112
    [No Abstract]   [Full Text] [Related]  

  • 6. Rat kidney graft survival after elimination of MHC class II-positive cells by perfusion with monoclonal antibody.
    Oko A; Krzymański M; Deja A; Pawliczak E; Idasiak-Piechocka I
    Transplant Proc; 1996 Dec; 28(6):3480-2. PubMed ID: 8962353
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.
    Glass B; Uharek L; Gaska T; Gassmann W; Löffler H; Müller-Ruchholtz W
    Bone Marrow Transplant; 1993; 12 Suppl 3():S41-7. PubMed ID: 8124257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for processing of WAG antigens by the RT1-D class II MHC molecules of PVG rats during kidney allograft rejection.
    Priestley CA; Spencer SS; Sawyer GJ; Fabre JW
    Transplant Proc; 1990 Aug; 22(4):1947-8. PubMed ID: 2389491
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged survival of rat cardiac allografts induced by intrathymic injection of donor bone marrow cells.
    Matsuura T; Hara Y; Imanishi M; Kanda H; Kurita T
    Transplant Proc; 1993 Dec; 25(6):3283-5. PubMed ID: 8266544
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
    Hess AD; Horwitz LR; Laulis MK
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1218-21. PubMed ID: 8442094
    [No Abstract]   [Full Text] [Related]  

  • 11. Donor pretreatment with IFN-gamma enhances MHC class II antigen expression and accelerates graft rejection by modified recipients.
    Ijzermans JN; Bouwman E; Jeekel J; Marquet RL
    Transplant Proc; 1990 Aug; 22(4):1941-2. PubMed ID: 2117821
    [No Abstract]   [Full Text] [Related]  

  • 12. Expression of major histocompatibility complex molecules in rodent retina. Immunohistochemical study.
    Zhang J; Wu GS; Ishimoto S; Pararajasegaram G; Rao NA
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1848-57. PubMed ID: 9286275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex class II expression is required for posttransplant immunological but not hemopoietic reconstitution in mice.
    Huss R; Beckham C; Storb R; Deeg HJ
    Transplantation; 1994 Dec; 58(12):1366-71. PubMed ID: 7809930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of cytomegalovirus infection and acute rejection after allogeneic lung transplantation in the rat: virus-induced expression of major histocompatibility complex class II antigens.
    You XM; Steinmüller C; Wagner TO; Bruggeman CA; Haverich A; Steinhoff G
    J Heart Lung Transplant; 1996 Nov; 15(11):1108-19. PubMed ID: 8956120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance induced by direct inoculation of donor antigen into the thymus in low and high responder rodents.
    Alfrey EJ; Wang X; Lee L; Holm B; Kim J; Adams G; Dafoe DC
    Transplantation; 1995 Apr; 59(8):1171-6. PubMed ID: 7732564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relative importance of local versus systemic immune response in allograft rejection.
    Ruers TJ; Buurman WA; van der Linden CJ
    Transplant Proc; 1989 Feb; 21(1 Pt 1):149-50. PubMed ID: 2650097
    [No Abstract]   [Full Text] [Related]  

  • 18. Mixed chimerism demonstrated in rats which have accepted heart allografts by intrathymic administration of bone marrow cells.
    Tahara H; Matsuura T; Imanishi M; Hara Y; Kurita T
    Transplant Proc; 1994 Aug; 26(4):1969. PubMed ID: 8066637
    [No Abstract]   [Full Text] [Related]  

  • 19. Rapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.
    Wu T; Sozen H; Luo B; Heuss N; Kalscheuer H; Lan P; Sutherland DE; Hering BJ; Guo Z
    Bone Marrow Transplant; 2002 Jun; 29(12):949-56. PubMed ID: 12098061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model.
    Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K
    J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.